Y
Yutaro Akiyama
Publications - 32
Citations - 279
Yutaro Akiyama is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 23 publications receiving 98 citations.
Papers
More filters
Journal ArticleDOI
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies.
Kenta Noda,Kouki Matsuda,Shigehiro Yagishita,Kenji Maeda,Yutaro Akiyama,Junko Terada-Hirashima,Hiromichi Matsushita,Satoshi Iwata,Kazuto Yamashita,Yusuke Atarashi,Shunsuke Watanabe,Nobuyuki Ide,Tomokazu Yoshida,Norio Ohmagari,Hiroaki Mitsuya,Hiroaki Mitsuya,Akinobu Hamada +16 more
TL;DR: In this article, the authors developed a diagnostic test that detects SARS-CoV-2 IgG and IgM with high quantitativeness and reproducibility and low interference.
Journal ArticleDOI
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
Daisuke Katagiri,Masahiro Ishikane,Yusuke Asai,Shinyu Izumi,Jin Takasaki,Hiyori Katsuoka,Isao Kondo,Satoshi Ide,Keiji Nakamura,Takato Nakamoto,Hidetoshi Nomoto,Yutaro Akiyama,Yusuke Miyazato,Tetsuya Suzuki,Noriko Kinoshita,Tatsunori Ogawa,Tomiteru Togano,Manabu Suzuki,Masao Hashimoto,Keita Sakamoto,Yusaku Kusaba,Takashi Katsuno,Takashi Fukaya,Masayuki Hojo,Masaya Sugiyama,Masashi Mizokami,Tatsuya Okamoto,Akio Kimura,Eisei Noiri,Norio Ohmagari,Fumihiko Hinoshita,Haruhito Sugiyama +31 more
TL;DR: To evaluate the efficacy and safety of direct hemoperfusion using a polymyxin B‐immobilized polystyrene column (PMX‐DHP) in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive pneumonia patients, a large number of patients were diagnosed with pneumonia.
Journal ArticleDOI
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine
Kayoko Hayakawa,Satoshi Kutsuna,Takeo Kawamata,Yuko Sugiki,Chiharu Nonaka,Keiko Tanaka,Michi Shoji,Masaki Nagai,Shunsuke Tezuka,Kazuyuki Shinya,Hiroki Saito,Takahiro Harada,Nin Moriya,Motoyuki Tsuboi,Masataro Norizuki,Yasuo Sugiura,Yasuyo Osanai,Masaya Sugiyama,Ayako Okuhama,Kohei Kanda,Yuji Wakimoto,Mugen Ujiie,Shinichiro Morioka,Kei Yamamoto,Noriko Kinoshita,Masahiro Ishikane,Sho Saito,Yuki Moriyama,Masayuki Ota,Keiji Nakamura,Takato Nakamoto,Satoshi Ide,Hidetoshi Nomoto,Yutaro Akiyama,Tetsuya Suzuki,Yusuke Miyazato,Yoshiaki Gu,Nobuaki Matsunaga,Shinya Tsuzuki,Yumiko Fujitomo,Yoshiki Kusama,Hiroyuki Shichino,Masao Kaneshige,Junko Yamanaka,Miki Saito,Masayuki Hojo,Masao Hashimoto,Shinyu Izumi,Jin Takasaki,Manabu Suzuki,Keita Sakamoto,Yukio Hiroi,Sakurako Emoto,Makoto Tokuhara,Toshiaki Kobayashi,Koichiro Tomiyama,Fumihiko Nakamura,Norio Ohmagari,Haruhito Sugiyama +58 more
TL;DR: NCGM participated in a large-scale operation to evacuate Japanese nationals from the COVID-19 epidemic area and was able to establish a scheme through this experience that can be used in the future.
Journal ArticleDOI
Effectiveness of Personal Protective Equipment in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Healthcare Workers
Tetsuya Suzuki,Kayoko Hayakawa,Akira Ainai,Naoko Iwata-Yoshikawa,Kaori Sano,Noriyo Nagata,Tadaki Suzuki,Yuji Wakimoto,Yutaro Akiyama,Yusuke Miyazato,Keiji Nakamura,Satoshi Ide,Hidetoshi Nomoto,Takato Nakamoto,Masayuki Ota,Yuki Moriyama,Yuko Sugiki,Sho Saito,Shinichiro Morioka,Masahiro Ishikane,Noriko Kinoshita,Satoshi Kutsuna,Norio Ohmagari +22 more
TL;DR: The study provides evidence that appropriate PPE is sufficient to prevent infection among HCWs and is necessary to establish a system that provides a stable supply of PPE for HCWs to perform their duties.
Journal ArticleDOI
Case of adult large vessel vasculitis after SARS-CoV-2 infection.
Ryohei Oda,Takeshi Inagaki,Masahiro Ishikane,Masatoshi Hotta,Akira Shimomura,Mitsuhiro Sato,Takato Nakamoto,Yutaro Akiyama,Kei Yamamoto,Ryogo Minamimoto,Hiroshi Kaneko,Norio Ohmagari +11 more
TL;DR: It was showed that glucocorticoid exposure of ≥10 mg/day was associated with higher odds of hospitalisation and anti-TNF with a decreased odds ofospitalisation in patients with COVID-19 with rheumatic disease.